Sezai, A.; Abe, M.; Maruyama, T.; Taoka, M.; Sekino, H.; Tanaka, M.
A Prospective Randomized Controlled Clinical Study to Investigate the Efficacy and Safety of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia Switched from Continuous Erythropoietin Receptor Activator Treatment. J. Clin. Med. 2024, 13, 2764.
https://doi.org/10.3390/jcm13102764
AMA Style
Sezai A, Abe M, Maruyama T, Taoka M, Sekino H, Tanaka M.
A Prospective Randomized Controlled Clinical Study to Investigate the Efficacy and Safety of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia Switched from Continuous Erythropoietin Receptor Activator Treatment. Journal of Clinical Medicine. 2024; 13(10):2764.
https://doi.org/10.3390/jcm13102764
Chicago/Turabian Style
Sezai, Akira, Masanori Abe, Takashi Maruyama, Makoto Taoka, Hisakuni Sekino, and Masashi Tanaka.
2024. "A Prospective Randomized Controlled Clinical Study to Investigate the Efficacy and Safety of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia Switched from Continuous Erythropoietin Receptor Activator Treatment" Journal of Clinical Medicine 13, no. 10: 2764.
https://doi.org/10.3390/jcm13102764
APA Style
Sezai, A., Abe, M., Maruyama, T., Taoka, M., Sekino, H., & Tanaka, M.
(2024). A Prospective Randomized Controlled Clinical Study to Investigate the Efficacy and Safety of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia Switched from Continuous Erythropoietin Receptor Activator Treatment. Journal of Clinical Medicine, 13(10), 2764.
https://doi.org/10.3390/jcm13102764
